CSF1R blockade remodels, rather than depletes, TAMs in proneural glioma models and constrains tumor growth, establishing a paradigm of pharmacologic reprogramming of maintenance signals; subsequent studies corroborate antitumor effects of CSF1R inhibition and highlight context dependence that argues for biomarker-guided selection (15, 73). Here, CSF1R is linked to central nervous system cancer.